Phenotypic Resistance of Campylobacter Isolates to an Extended Panel of Antibiotics
The American Journal of Tropical Medicine and Hygiene · 2026
DOI: 10.4269/ajtmh.26-0268 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2026. Verfasst von Lucero Romaina Cachique und 12 weiteren Autor:innen. Beteiligte Einrichtung: Asociacion Benefica PRISMA, Iquitos, Peru. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Campylobacter, Drug Resistance, Bacterial, Drug Resistance, Multiple, Bacterial. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FIC NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Because of the global increase in resistance of Campylobacter to both fluoroquinolones and macrolides, we explored phenotypic resistance using traditional Kirby–Bauer methods in human- and animal-derived Campylobacter isolates that were concurrently resistant to both azithromycin and ciprofloxacin to an expanded panel of antimicrobials, including clindamycin, fosfomycin, ampicillin and sulbactam, amoxicillin and clavulanic, fosfomycin, tigecycline, and imipenem. Of 235 Campylobacter isolates resistant to ciprofloxacin and azithromycin, more than 94.8% of Campylobacter jejuni and Campylobacter coli were resistant to clindamycin, 68.5% were resistant to ampicillin and sulbactam, 2.6% were resistant to amoxicillin and clavulanic, and 36.2% were resistant to fosfomycin. Less than 2% of isolates were resistant to tigecycline, and there was no observed resistance to imipenem. The results suggest that amoxicillin and clavulanic warrant further evaluation for use in Campylobacter enteritis in ambulatory patients, but it points to no clear alternative oral therapies. Study findings were reassuring in demonstrating continued universal susceptibility to carbapenems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Asociacion Benefica PRISMA, Iquitos, Peru.
- Faculty of Veterinary Medicine, Universidad Peruana Cayetano Heredia, San Martin de Porres, Lima, Peru.
- Division of Infectious Diseases and International Health, School of Medicine, University of Virginia, Charlottesville, Virginia, USA.
- School of Animal and Comparative Biomedical Sciences, University of Arizona, Tucson, Arizona, USA.
- Zoonosis Science Center, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
- Ineos Oxford Institute for Antimicrobial Research, Department of Biology, University of Oxford, Oxford, United Kingdom.
Förderung
- FIC NIH HHS
- NIAID NIH HHS
Zitieren
APA
Romaina Cachique, L., Schiaffino, F., Paredes Olortegui, M., Manzanares, K., Pinedo Vasquez, T., Castro, A., Najarro, J., Cooper, K. K., Mourkas, E., Pascoe, B., Peñataro Yori, P., Parker, C. T., & Kosek, M. N. (2026). Phenotypic Resistance of Campylobacter Isolates to an Extended Panel of Antibiotics. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.26-0268
Vancouver
Romaina Cachique L, Schiaffino F, Paredes Olortegui M, Manzanares K, Pinedo Vasquez T, Castro A, et al. Phenotypic Resistance of Campylobacter Isolates to an Extended Panel of Antibiotics. The American Journal of Tropical Medicine and Hygiene. 2026. doi:10.4269/ajtmh.26-0268
BibTeX
@article{RomainaCachique2026,
author = {Romaina Cachique, Lucero and Schiaffino, Francesca and Paredes Olortegui, Maribel and Manzanares, Katia and Pinedo Vasquez, Tackeshy and Castro, Alejandra and Najarro, Juana and Cooper, Kerry K and Mourkas, Evangelos and Pascoe, Ben and Peñataro Yori, Pablo and Parker, Craig T and Kosek, Margaret N},
title = {Phenotypic Resistance of Campylobacter Isolates to an Extended Panel of Antibiotics},
journal = {The American Journal of Tropical Medicine and Hygiene},
year = {2026},
doi = {10.4269/ajtmh.26-0268}
}
EUVIMED